Jeffrey C. JOHNSON

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies with low immunogenicity and uses thereof
- Patent number 11,427,632
- Issue date Aug 30, 2022
- Celgene Corporation
- Jeffrey C. Johnson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY
- Publication number 20240075133
- Publication date Mar 7, 2024
- Celgene Corporation
- Jeffrey C. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDIT...
- Publication number 20230365681
- Publication date Nov 16, 2023
- Celgene Corporation
- Haralambos HADJIVASSILIOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47
- Publication number 20220340675
- Publication date Oct 27, 2022
- Celgene Corporation
- Haralambos HADJIVASSILIOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47
- Publication number 20220162330
- Publication date May 26, 2022
- Celgene Corporation
- Haralambos HADJIVASSILIOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY
- Publication number 20200330590
- Publication date Oct 22, 2020
- Celgene Corporation
- Jeffrey C. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES WITH LOW IMMUNOGENICITY AND USES THEREOF
- Publication number 20190241654
- Publication date Aug 8, 2019
- Celgene Corporation
- Jeffrey C. JOHNSON
- C07 - ORGANIC CHEMISTRY

Jeffrey C. JOHNSON

Person

Patents Grantslast 30 patents

Antibodies with low immunogenicity and uses thereof

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY

BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDIT...

ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

METHODS AND COMPOSITIONS FOR REDUCTION OF IMMUNOGENICITY

ANTIBODIES WITH LOW IMMUNOGENICITY AND USES THEREOF